Anthem Biosciences Ltd
Anthem Biosciences Ltd Share Price Today: Live Updates & Key Insights
Get insights on Anthem Biosciences Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.
Anthem Biosciences Ltd Share Price Chart
Anthem Biosciences Ltd Fundamentals
Traded Volume: 8,04,021
Market Cap(Cr): 36,302
Avg Traded Price 646.33
1 Year return %
Upper Circuit 656
Lower Circuit 645.7
P/E TTM 70.00
P/B Ratio 15.139
Traded Value(Cr) 5197.19
EPS TTM 9.191
Book value/Share 43.100
Dividend Yield 1Y 0.00%
Anthem Biosciences Ltd Share Price Performance
Shows the percentage change in stock price over different time periods
This section highlights Anthem Biosciences Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Anthem Biosciences Ltd share price history, short-term movements, long-term trends, and overall investor sentiment
1W +1.84%
1M -7.21%
3M -22.10%
1Y N/A%
YTD N/A%
Anthem Biosciences Ltd Traded Volume Movement
Shows the trading volume over different time periods
This section highlights Anthem Biosciences Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment
Yesterday 1.73L
Day Before Yesterday 1.54L
1W Avg 4.09L
1M Avg 5.32L
3M Avg 4.57L
Anthem Biosciences Ltd Technical Details
Anthem Biosciences Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.
Support 1 648
Support 2 642
Support 3 635
Pivot Point : 655
Resistance 1 661
Resistance 2 668
Resistance 3 674
Anthem Biosciences Ltd Corporate Actions
Anthem Biosciences Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Anthem Biosciences Ltd’s capital allocation strategies.
All
Dividends
No Dividend has been declared by ANTHEM
Bonus
No Bonus has been declared by ANTHEM
Splits
No Split has been declared by ANTHEM
Others
Rights No Rights has been declared by ANTHEM
Anthem Biosciences Ltd Peer Comparison
Shows key financial metrics for the company and its peers
This section compares Anthem Biosciences Ltd with leading peers in the banking sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Anthem Biosciences Ltd's relative performance and valuation against major competitors.
Stock Name Laurus Labs Ltd ₹1013.90 (-1.19%) M. Cap (Cr) 547.36 1 Yr Return (%) +72.33% P/E (TTM) 80.06 PB Ratio 12.24
Stock Name Glaxosmithkline Pharmaceuticals Ltd ₹2530.00 (-0.61%) M. Cap (Cr) 428.60 1 Yr Return (%) +6.25% P/E (TTM) 44.80 PB Ratio 21.93
Stock Name Ipca Laboratories Ltd ₹1454.60 (-0.31%) M. Cap (Cr) 369.04 1 Yr Return (%) -2.59% P/E (TTM) 44.44 PB Ratio 5.32
Stock Name Anthem Biosciences Ltd ₹646.40 (-1.23%) M. Cap (Cr) 363.02 1 Yr Return (%) NaN% P/E (TTM) 70.31 PB Ratio 15.06
Stock Name Ajanta Pharma Ltd ₹2675.00 (+1.30%) M. Cap (Cr) 334.20 1 Yr Return (%) -8.21% P/E (TTM) 34.42 PB Ratio 9.11
Stock Name J B Chemicals & Pharmaceuticals Ltd ₹1813.10 (-0.67%) M. Cap (Cr) 284.02 1 Yr Return (%) +1.93% P/E (TTM) 39.58 PB Ratio 8.85
Stock Name Gland Pharma Ltd ₹1726.50 (-1.43%) M. Cap (Cr) 284.45 1 Yr Return (%) -5.87% P/E (TTM) 35.99 PB Ratio 3.11
Anthem Biosciences Ltd Cash Flow
Cash flow data provides a view of how money is generated and spent by Anthem Biosciences Ltd, across its operating activities, investing activities, and financing activities.
PARTICULARS Operating Activities Mar 2025 439.84 Mar 2024 164.41 Mar 2023 318.98 Mar 2022 333.35 Mar 2021 277.54
PARTICULARS Investing Activities Mar 2025 -246.31 Mar 2024 -191.76 Mar 2023 -377.91 Mar 2022 -205.78 Mar 2021 -196.09
PARTICULARS Financing Activities Mar 2025 -66.42 Mar 2024 -131.59 Mar 2023 52.85 Mar 2022 180.68 Mar 2021 -63.26
PARTICULARS Net Cash Flow Mar 2025 127.10 Mar 2024 -158.95 Mar 2023 -6.07 Mar 2022 308.24 Mar 2021 18.19
Anthem Biosciences Ltd Shareholding Pattern
This shows the ownership breakdown of Anthem Biosciences Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.
Promoter 74.69%
Public 16.42%
Other Institutions 0.53%
FII 1.66%
Mutual Funds 6.68%
About Anthem Biosciences Ltd
Anthem Biosciences Limited was originally incorporated as Anthem Biosciences Private Limited, dated June 13, 2006, issued by RoC. Subsequently, Company was converted from a Private Company to a Public Company , followed by the change in name of the Company to Anthem Biosciences Limited and a Certificate of Incorporation was issued by RoC on December 10, 2024.The Company has been set up as a Life sciences/ Biotechnology based venture specialising in the manufacture of catalytic preparation, other organic compounds such as speciality organic molecules, biologically active peptides etc., which are high-value products used in drug, agrochemical and speciality chemicals industries.The Company started operations at Unit I and set up a Custom Synthesis Plant with a capacity of 6 KL in year 2007. It commenced discovery biology services with a fermentation capacity of 2 KL in 2008. It expanded the Custom Synthesis Plant at Unit I increasing its capacity from 6 KL to 24 KL in 2010. It set up a high potent lab at Unit I - Bommasandra Facility in 2016. The Company was merged with Anthem Cellutions (India) Private Limited by acquiring 100% of its share capital in November, 2017. It set up a flow chemistry lab scale and solid phase peptide synthesis GMP lab with a capacity of 6 KL at Unit 1. It commenced operations of the Company at Unit II and set up an automated GMP compliant custom synthesis plant with a capacity of 128 KL and a fermentation plant with a capacity of 80 KL in 2018-19. In year 2020, Company started operations to biological unit 2 earmarked for a specific client. It expanded the custom synthesis plant set up at Unit II increasing its capacity to 246 KL. In FY 2024, Company set up a wholly owned subsidiary Neoanthem Lifesciences Private Limited and commenced operations at Unit III for development in projects. Company launched the initial public offering of 59,575,319 equity shares of face value of Rs 2 each by raising funds through offer for sale aggregating to Rs 3395 Crore in July, 2025. The Company expanded the fermentation capacity to 140 KL at the Unit II in 2025.
Chairman & MD & CEO
Ajay Bhardwaj
Registered office 49 F1 & F2 Canara Bank Road, Bommasandra Industrial Area, Bangalore, Karnataka, 560099
FAX :+91 080 6672 4000
Background
Incorporation Year 2006
Face Value ₹2.00
Market Lot 1
FAQs on Anthem Biosciences Ltd
How to buy Anthem Biosciences Ltd shares on NSE?
To buy Anthem Biosciences Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified.
What is the Anthem Biosciences Ltd share price today?
The Anthem Biosciences Ltd share price on NSE is ₹646.40 today.
What is the market cap of Anthem Biosciences Ltd on NSE?
The company has a market capitalization of ₹36302.47.
What is the PE & PB ratio of Anthem Biosciences Ltd?
PE is 70 and PB is 9.
What is the 52 Week High and Low of Anthem Biosciences Ltd shares?
Anthem Biosciences Ltd stock price high: ₹873.50 Anthem Biosciences Ltd stock price low: ₹620.